Hai-Long Ma (Hailong Ma)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Long Noncoding Rna

Cone Beam Computed Tomography

Signaling Pathway

Top Venues

Cancer communications (London, England)

Molecular cancer

Cell death & disease

Clinical implant dentistry and related research

This page only lists publications with an associated author ORCID identifier.

Publications

Xin-Yu Zhang, Jian-Bo Shi, Shu-Fang Jin, Rui-Jie Wang, Ming-Yu Li, Zhi-Yuan Zhang, Xi Yang, Hai-Long Ma
Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec-15 axis in immune escape. Cancer communications (London, England) 44 (6) (2024)
Xin-Yu Zhang, Jian-Bo Shi, Shu-Fang Jin, Rui-Jie Wang, Ming-Yu Li, Zhi-Yuan Zhang, Xi Yang, Hai-Long Ma
Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec-15 axis in immune escape. Cancer communications (London, England) (2024)
Xin-Yu Zhang, Jian-Bo Shi, Shu-Fang Jin, Rui-Jie Wang, Ming-Yu Li, Zhi-Yuan Zhang, Xi Yang, Hai-Long Ma
Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec-15 axis in immune escape. Cancer communications (London, England) (2024)
Xin-Yu Zhang, Jian-Bo Shi, Shu-Fang Jin, Rui-Jie Wang, Ming-Yu Li, Zhi-Yuan Zhang, Xi Yang, Hai-Long Ma
Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec-15 axis in immune escape. Cancer communications (London, England) 44 (6) (2024)
Xin-Yu Zhang, Jian-Bo Shi, Shu-Fang Jin, Rui-Jie Wang, Ming-Yu Li, Zhi-Yuan Zhang, Xi Yang, Hai-Long Ma
Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec-15 axis in immune escape. Cancer communications (London, England) 44 (6) (2024)
Shufang Jin, Hai-Long Ma, Xiaowan Ling, Baoxin Tao, Feng Wang, Yi-Qun Wu
Longitudinal reactions of maxillary sinus in patients treated with multiple zygomatic implants: A modified radiographic evaluation with clinical follow-up. Clinical implant dentistry and related research (2023)
Chuwen Li, Haiyan Guo, Peisong Zhai, Ming Yan, Chun Liu, Xiaoning Wang, Chaoji Shi, Jiang Li, Tong Tong, Zhi-Yuan Zhang, Hai-Long Ma, Jianjun Zhang
Spatial and single-cell transcriptomics reveal a cancer-associated fibroblast subset in HNSCC that restricts infiltration and anti-tumor activity of CD8+ T cells. Cancer research (2023)
Shufang Jin, Mingyu Li, Hanyue Chang, Ruijie Wang, Zhiyuan Zhang, Jianjun Zhang, Yue He, Hai-Long Ma
The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma. Molecular cancer 21 (1) (2022)
Shufang Jin, Jiayi Li, Yihan Shen, Yi-Qun Wu, Zhiyuan Zhang, Hai-Long Ma
RNA 5-Methylcytosine Regulator NSUN3 promotes tumor progression through regulating immune infiltration in head and neck squamous cell carcinoma. Oral diseases (2022)
Hanyue Chang, Qiaoshi Xu, Jiayi Li, Mingyu Li, Zhiyuan Zhang, Hai-Long Ma, Xi Yang
Lactate secreted by PKM2 upregulation promotes Galectin-9-mediated immunosuppression via inhibiting NF-κB pathway in HNSCC. Cell death & disease 12 (8) (2021)
Qiaoshi Xu, Hai-Long Ma, Hanyue Chang, Zhien Feng, Chenping Zhang, Xi Yang
The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway. Cell death & disease 11 (5) (2020)
Hai-Long Ma, Hanyue Chang, Wenyi Yang, Yusheng Lu, Jingzhou Hu, Shufang Jin
A novel IFNα-induced long noncoding RNA negatively regulates immunosuppression by interrupting H3K27 acetylation in head and neck squamous cell carcinoma. Molecular cancer 19 (1) (2020)
Jiayi Li, Chaoji Shi, Rong Zhou, Yong Han, Shengming Xu, Hai-Long Ma, Zhiyuan Zhang
The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma. Cancer science 111 (9) (2020)
Shufang Jin, Xi Yang, Jiayi Li, Wenyi Yang, Hai-Long Ma, Zhiyuan Zhang
p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma. Molecular cancer 18 (1) (2019)